According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.

WHO’s director general described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the absence of a vaccine.

A GNA feature by Laudia Sawer Tema, July 12, GNA - On any ordinary morning, Maame Esi, an HIV mentor mother, stands among other mothers at the antenatal clinic of the Tema General Hospital, scanning ...

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

But in the last six months, the sudden withdrawal of U.S. money has caused a “systemic shock,” U.N. officials warned, adding ...

Millions of lives and decades of progress hang in the balance,” says the president of the International AIDS Society (IAS) ...

At a prison in the Catskill Mountains, where I used to be incarcerated, some men were trying to buck the trend.

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...